
The Molecular Pathology Institute
The Molecular Pathology Institute
We are The Molecular Pathology Institute, based in Nigeria.Â
The Molecular Pathology Institute is an Independent Research Organization (IRO) focusing on genomic science, molecular diagnostics, and data science (US SIC Code 8732). It is a multi-disciplinary, not-for-profit, non-partisan IRO, limited by guarantee, RC1485899. It is registered with the Ministries of Health and Education in Nigeria. It is regulated by the Corporate Affairs Commission and the Ministries of Health and Education.Â
DUNS No: 561347085.
The MPI is designed to provide cutting-edge research and catalyze the growth of genomic science in Nigeria. Our research is both basic and applied.
It houses the Safety Molecular Pathology Laboratory, a leading Molecular Diagnostics laboratory, accredited by both the MLSCN and NCDC. It is a COVID 19 RNA PCR Testing Centre.
Our Strategy
Strategic Pillars
Build capacity
Invest in technology
Provide solutions to health issues
Pursue discoveries in genomic science
Collaborate with academia and industry

The MPI Way
Approach, Vision, Mission
Vision
Integrate genomic and data science and molecular diagnostics into daily life in Nigeria. We invest in discovery science and also work to translate bench discoveries to bedside benefits. Developing local talents and supporting them to grow to international repute is our way.
Mission
Provide accessible, affordable and reliable molecular diagnostics to the society through research, development and dissemination of information.
The MPI Approach:
Protect the environment.
Involve the public in every step.
Invest in young scientists and entrepreneurs.
Identify core areas of needs in diagnostic medicine.
Engage in research and provide solutions to the society.
Increase access to and availability of molecular diagnostics at affordable costs
![]() | ![]() | ![]() |
---|---|---|
![]() |
Partnerships
Our Partners
Partnerships
1. Safety Molecular Pathology Laboratory SMPL
2. Prostate Disease Research Foundation PDRF
3. Safety Clinical Trials & Data Mgt SCTDM
4. Oxford Medical & Scientific Ltd OMSL